SNK01

· NKGen Biotech, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SNK01, covering 2021-07-21 to 2025-11-10. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease [Phase 1, Phase 2]